[Pharmacogenetics, tobacco, alcohol and its effect on the risk development cancer].

Cancer is the second leading cause of death in the world, causing 8.8 million deaths in 2015 according to the World Health Organization (WHO). Risk factors for cancer include smoking and alcohol con sumption. In Chile, 33.6% of the population and 21.2% of young people smokes. Alcohol consump tion in the Chilean population is 74.5% and 12.2% in young people. Among the physiological factors that influence the development of cancer, the genetic factor plays a relevant role. It has been shown that the presence of genetic polymorphisms that alter the ability of the body to eliminate contami nants increase the risk of developing cancer. The same applies to polymorphisms that prevent DNA repair due to damage caused by environmental pollutants such as cigarette smoke. The objective of this review is to analyze the state of the art of the relationship between pharmacogenetics, smoking, and alcohol consumption as risk factors for the development of cancer. In conclusion, the results suggest that the presence of polymorphisms that alter the function of biotransformation enzymes phase I (CYP1A1, CYP1E1) and phase II (GST), as well as polymorphisms in DNA repair enzymes (ERCC1 / ERCC2), increase the risk of cancer induced by smoking and alcohol consumption. This association is important considering that smoking and drinking alcohol are highly prevalent among the Chilean population.

[1]  Angie Margarita,et al.  Factores genéticos relacionados con la variabilidad en la respuesta a la quimioterapia en pacientes con cáncer testicular , 2018 .

[2]  E. Giovannucci,et al.  Alcohol as a Risk Factor for Cancer. , 2016, Seminars in oncology nursing.

[3]  W. Lei,et al.  GSTT1 Null Genotype Significantly Increases the Susceptibility to Urinary System Cancer: Evidences from 63,876 Subjects , 2016, Journal of Cancer.

[4]  R. Zhao,et al.  Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population. , 2016, Genetics and molecular research : GMR.

[5]  S. Awasthi,et al.  Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling. , 2015, Toxicology and applied pharmacology.

[6]  J. Kładny,et al.  Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population , 2014, Molecular Biology Reports.

[7]  A. Lewis,et al.  Exposure to nitrosamines in thirdhand tobacco smoke increases cancer risk in non-smokers. , 2014, Environment international.

[8]  W. Dong,et al.  XPD Asp312Asn polymorphism and esophageal cancer risk: an update meta-analysis based on 3928 cases and 6012 controls. , 2014, International journal of clinical and experimental medicine.

[9]  Jian-rong Huang,et al.  A Meta-Analysis of Parental Smoking and the Risk of Childhood Brain Tumors , 2014, PloS one.

[10]  M. Dobreanu,et al.  Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia , 2014, BioMed research international.

[11]  K. Syrigos,et al.  Lung cancer in never smokers: disease characteristics and risk factors. , 2013, Critical reviews in oncology/hematology.

[12]  D. Pašalić,et al.  Polymorphisms of genes involved in polycyclic aromatic hydrocarbons’ biotransformation and atherosclerosis , 2013, Biochemia medica.

[13]  O. Schärer.  Nucleotide excision repair in eukaryotes. , 2013, Cold Spring Harbor perspectives in biology.

[14]  A. Roco,et al.  Frequencies of 23 Functionally Significant Variant Alleles Related with Metabolism of Antineoplastic Drugs in the Chilean Population: Comparison with Caucasian and Asian Populations , 2012, Front. Gene..

[15]  Yan Lu,et al.  The Effect of XPD/ERCC2 Polymorphisms on Gastric Cancer Risk among Different Ethnicities: A Systematic Review and Meta-Analysis , 2012, PloS one.

[16]  Y. Kakeji,et al.  Genetic Polymorphisms of XRCC1, Alcohol Consumption, and the Risk of Colorectal Cancer in Japan , 2011, Journal of epidemiology.

[17]  R. Peto,et al.  The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 , 2011, British Journal of Cancer.

[18]  G. Coronado,et al.  Alcohol consumption and the risk of breast cancer. , 2011, Salud publica de Mexico.

[19]  L. Tone,et al.  Increased Risk for Acute Lymphoblastic Leukemia in Children with Cytochrome P450 A1(CYP1A1)- and NAD(P)H:Quinone Oxidoreductase 1 (NQO1)-Inherited Gene Variants , 2010, Acta Haematologica.

[20]  A. Roco,et al.  Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals. , 2010, Oncology letters.

[21]  D. Hémon,et al.  Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy and childhood malignant central nervous system tumours: the ESCALE study (SFCE)* , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  N. Nock,et al.  Associations between Smoking, Polymorphisms in Polycyclic Aromatic Hydrocarbon (PAH) Metabolism and Conjugation Genes and PAH-DNA Adducts in Prostate Tumors Differ by Race , 2007, Cancer Epidemiology Biomarkers & Prevention.

[23]  D. Cáceres,et al.  Variantes alélicas de CYP1A1 y GSTM1 como biomarcadores de susceptibilidad a cáncer gástrico: influencia de los hábitos tabáquico y alcohólico , 2006 .

[24]  S. Benhamou,et al.  ERCC2/XPD gene polymorphisms and cancer risk. , 2002, Mutagenesis.

[25]  L. Quiñones,et al.  CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. , 2001, Cancer letters.

[26]  R. Parshad,et al.  XPD polymorphisms: effects on DNA repair proficiency. , 2000, Carcinogenesis.

[27]  F. Berthou,et al.  Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations. , 1999, Cancer letters.

[28]  S. Glantz,et al.  Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. , 1997, Circulation.

[29]  J. Brockmöller,et al.  A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. , 1996, Cancer research.

[30]  I. Gallardo,et al.  Estrés oxidante: el sistema enzimático glutatión y la salud bucal , 2014 .

[31]  Lin Xu,et al.  Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis. , 2012, Mutagenesis.

[32]  H. Seitz,et al.  Alcohol Metabolism and Cancer Risk , 2007, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[33]  S. Benhamou,et al.  ERCC 2 / XPD gene polymorphisms and cancer risk , 2002 .

[34]  R. Breslow,et al.  Original Contribution Prospective Study of Alcohol Consumption Quantity and Frequency and Cancer-specific Mortality in the Us Population , 2022 .